Latest News of HRTX
With 55% ownership of the shares, Heron Therapeutics, Inc. (NASDAQ:HRTX) is heavily dominated by institutional owners
By Yahoo! Finance |
4 months ago
Ownership data and analyst forecasts provide valuable insights into a company's potential success. Institutional investors hold a majority stake in Heron Therapeutics, indicating confidence in its fut...